loadpatents
name:-0.037440061569214
name:-0.013911962509155
name:-0.0025489330291748
HEIDER; Karl-Heinz Patent Filings

HEIDER; Karl-Heinz

Patent Applications and Registrations

Patent applications and USPTO patent grants for HEIDER; Karl-Heinz.The latest application filed is for "anti-cd37 antibodies".

Company Profile
1.15.38
  • HEIDER; Karl-Heinz - Stockerau AT
  • HEIDER; Karl-Heinz - Ingelheim am Rhein DE
  • Heider; Karl-Heinz - Ingelheim DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-cd37 Antibodies
App 20210230271 - HEIDER; Karl-Heinz ;   et al.
2021-07-29
Cd33 Binding Agents
App 20190256593 - KONOPITZKY; Renate ;   et al.
2019-08-22
CD33 binding agents
Grant 10,202,451 - Konopitzky , et al. Feb
2019-02-12
Anti Cd37 Antibodies
App 20180186876 - HEIDER; Karl-Heinz ;   et al.
2018-07-05
Anti CD37 antibodies
Grant 9,932,399 - Heider , et al. April 3, 2
2018-04-03
Pharmaceutical Combinations Comprising Cd33 Antibodies And De-methylating Agents
App 20180064811 - HEIDER; Karl-Heinz
2018-03-08
Cd33 Binding Agents
App 20170088617 - KONOPITZKY; Renate ;   et al.
2017-03-30
CD33 binding agents
Grant 9,550,833 - Konopitzky , et al. January 24, 2
2017-01-24
Anti Cd37 Antibodies
App 20160137729 - HEIDER; Karl-Heinz ;   et al.
2016-05-19
Combination Of Cd37 Antibodies With Chlorambucil
App 20160106837 - HEIDER; Karl-Heinz ;   et al.
2016-04-21
Cd33 Binding Agents
App 20150284462 - KONOPITZKY; Renate ;   et al.
2015-10-08
Superior Efficacy Of Cd37 Antibodies In Cll Blood Samples
App 20150266967 - STILGENBAUER; Stephan ;   et al.
2015-09-24
Combination Of Cd37 Antibodies With Bendamustine
App 20150231242 - HEIDER; Karl-Heinz ;   et al.
2015-08-20
Anti CD37 antibodies
Grant 9,078,879 - Heider , et al. July 14, 2
2015-07-14
CD33 binding agents
Grant 9,079,958 - Konopitzky , et al. July 14, 2
2015-07-14
Pharmaceutical Combinations Comprising Cd33 Antibodies And De-methylating Agents
App 20150125447 - HEIDER; Karl-Heinz
2015-05-07
Combination of CD37 antibodies with ICE
Grant 8,992,915 - Heider , et al. March 31, 2
2015-03-31
Anti Cd37 Antibodies
App 20140010808 - HEIDER; Karl-Heinz ;   et al.
2014-01-09
Anti Cd37 Antibodies
App 20140004110 - HEIDER; Karl-Heinz ;   et al.
2014-01-02
Combination Of Cd37 Antibodies With Ice
App 20130309225 - HEIDER; Karl-Heinz ;   et al.
2013-11-21
Combination Of Cd37 Antibodies With Rituximab
App 20130309224 - HEIDER; Karl-Heinz ;   et al.
2013-11-21
Combination Of Cd37 Antibodies With Bendamustine
App 20130287797 - HEIDER; Karl-Heinz ;   et al.
2013-10-31
Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them
Grant 8,568,727 - Adolf , et al. October 29, 2
2013-10-29
Superior Efficacy Of Cd37 Antibodies In Cll Blood Samples
App 20130236454 - STILGENBAUER; Stephan ;   et al.
2013-09-12
Superior Efficacy Of Cd37 Antibodies In Cll Blood Samples
App 20120189618 - Stilgenbauer; Stephan ;   et al.
2012-07-26
Cd33 Binding Agents
App 20120082670 - KONOPITZKY; Renate ;   et al.
2012-04-05
Anti Cd37 Antibodies
App 20110165153 - HEIDER; Karl-Heinz ;   et al.
2011-07-07
Anti Cd37 Antibodies
App 20100189722 - Heider; Karl-Heinz ;   et al.
2010-07-29
Antibodies to interleukin-like epithelial-mesenchymal transition inducer (ILEI)
Grant 7,745,585 - Zophel , et al. June 29, 2
2010-06-29
Antibody Molecules Specific for Fibroblast Activation Protein and Immunoconjugates Containing Them
App 20090304718 - Adolf; Guenther ;   et al.
2009-12-10
Antibodies specific for CD44v6
Grant 7,417,127 - Adolf , et al. August 26, 2
2008-08-26
Cytotoxic CD44 antibody immunoconjugates
Grant 7,361,347 - Adolf , et al. April 22, 2
2008-04-22
Cytokine involved in epithelial-mesenchymal transition
App 20070089176 - Zoephel; Andreas ;   et al.
2007-04-19
Cytotoxic CD44 antibody immunoconjugates
App 20050271672 - Adolf, Guenther ;   et al.
2005-12-08
Antibodies specific for CD44v6
Grant 6,972,324 - Adolf , et al. December 6, 2
2005-12-06
Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agents
App 20050244413 - Adolf, Guenther ;   et al.
2005-11-03
Antibodies specific for CD44v6
App 20050214212 - Adolf, Gunther ;   et al.
2005-09-29
Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agents
App 20040126379 - Adolf, Guenther ;   et al.
2004-07-01
Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapy
App 20040120949 - Adolf, Guenther ;   et al.
2004-06-24
Antibodies specific for CD44v6
App 20030190319 - Adolf, Gunther ;   et al.
2003-10-09
Cytotoxic CD44 antibody immunoconjugates
App 20030103985 - Adolf, Guenther ;   et al.
2003-06-05
Method for diagnosis and therapy of Hodgkin's lymphomas
App 20030032073 - Heider, Karl-Heinz ;   et al.
2003-02-13
Pharmaceutical compositions for treating tumour diseases
App 20020127542 - Beug, Hartmut ;   et al.
2002-09-12
Methods of screening for pharmacologically active compounds for the treatment of tumour diseases
Grant 6,383,733 - Beug , et al. May 7, 2
2002-05-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed